Results 101 to 110 of about 51,404 (237)

Coexistence of psoriasis with bullous pemphigoid

open access: yesIndian Dermatology Online Journal, 2012
Psoriasis vulgaris and bullous pemphigoid (BP) represent two clinically well-characterized, chronic, inflammatory skin conditions. The concomitant occurrence of these two entities in a patient is rare.
Raghavendra Rao   +4 more
doaj   +1 more source

Immunoglobulin E-Mediated Autoimmunity [PDF]

open access: yes, 2018
The study of autoimmunity mediated by immunoglobulin E (IgE) autoantibodies, which may be termed autoallergy, is in its infancy. It is now recognized that systemic lupus erythematosus, bullous pemphigoid (BP), and chronic urticaria, both spontaneous and ...
Altrichter, Sabine   +5 more
core   +1 more source

Acute periodontal lesions [PDF]

open access: yes, 2014
This is a review and update on acute conditions affecting the gingival tissues, including abscesses in the periodontium, necrotizing periodontal diseases, and other acute conditions that cause gingival lesions with acute presentation, such as infectious ...
AAP   +340 more
core   +1 more source

The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations

open access: yesFrontiers in Medicine, 2018
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the annual incidence of BP has been estimated to be between 2.
K. Kridin, R. Ludwig
semanticscholar   +1 more source

Paraneoplastic pemphigus with clinical features of lichen planus associated with low-grade B cell lymphoma [PDF]

open access: yes, 2005
BACKGROUND: Neoplasia-induced lichen planus is described as a cell-mediated reaction to unknown epithelial antigens. Paraneoplastic pemphigus (PNP), characterized by the presence of a specific array of autoantibodies, probably represents a different form
Black, M   +4 more
core   +1 more source

Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients

open access: yesJAMA dermatology, 2018
Importance The association of bullous pemphigoid (BP) with the use of dipeptidyl-peptidase 4 (DPP-4) inhibitors among patients with diabetes has recently emerged. The risk of developing BP during treatment with new DPP-4 inhibitor agents like linagliptin
K. Kridin, R. Bergman
semanticscholar   +1 more source

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

open access: yesFrontiers in Immunology, 2018
Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean   +9 more
doaj   +1 more source

The 'Spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families [PDF]

open access: yes, 2002
Recent studies have characterised a family of giant cytoskeletal crosslinkers encoded by the short stop gene in Drosophila and the dystonin/BPAG1 and MACF1 genes in mammals.
Brown, N., Gregory, S., Roeper, K.
core   +2 more sources

Pemphigoid gestationis and intravenous immunoglobulin therapy

open access: yesInternational Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH   +2 more
doaj  

The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease

open access: yesFrontiers in Medicine, 2018
Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant mortality and morbidity. While historically BP has been characterized as an IgG driven disease mediated by anti-BP180 and BP230 IgG autoantibodies, developments in ...
K. Amber   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy